Dear Editor-in-Chief Today, there is a question of whether tele-pharmacy could be a powerful tool during the COVID-19 pandemic to deliver health care across health care system. The Coronavirus disease (COVID-19) pandemic is rapidly spreading across the world. Based on World Health Organization (WHO), worldwide 6881352 people were infected with the Coronavirus, and 399895 died until 8 June 2020 [1]. COVID-19 is a respiratory virus, which means that patients with chronic lung disease (including asthma, chronic obstructive pulmonary disease, and emphysema), diabetes mel-litus, cardiovascular disease, chronic renal disease, chronic liver disease, immunocompromised condition, neurologic disorder, current smoker, former smoker are at increased risk of morbidity and mortality [2]. Because of the increased allergic reactions in the spring, allergic rhinitis of many patients may mistakenly be diagnosed as a symptom of COVID-19 [3]. Activities such as early diagnosis of the disease, isolation of the patients, monitoring of the contacts with suspected and confirmed cases, and public health quarantine are among the strategies taken to combat COVID-19 [4]. In this context, COVID-19 is changing the use of information technology in healthcare services. Telemedicine has achieved much more attention during this pandemic. Telemedicine provides electronic consultations and has reduced the risk of transmission by reducing in-person contact among people (self-quarantine) [4].
展开▼
